Clinical Trial

Insights Into Participating in Studies for Bone Cancer

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 6, 2023 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
Clinical studies, with a distinct focus on bone cancer, play a crucial role in evaluating the safety and effectiveness of novel treatments for this disease. These trials serve as instrumental means to determine whether new medications surpass conventional therapies, providing substantial evidence for their broader adoption. The primary objective is to meticulously scrutinize trial completion rates and voluntary withdrawals within this specific patient group.
Trial Details
NCT Number NCT06070259
Lead Sponsor Power Life Sciences Inc.
Conditions Bone Cancer
Enrollment 500 participants
Start Date 2024-10
Primary Completion 2025-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2023-10-06